IBM's Anderon Wins $1B CHIPS Grant, DARPA Taps IBM for Quantum Validation
IBM sits 20% above its 52-week low of $199.19.
Summary
IBM's subsidiary Anderon finalized a $1 billion CHIPS and Science Act award to scale a 300mm quantum wafer foundry in Albany, with IBM adding another $1 billion for a total $2 billion investment. First quantum wafers are already in production, and Mukesh Kare has been named CEO of Anderon. Separately, DARPA named IBM as a participant in its program to validate an error-corrected, utility-scale quantum computer by 2033. This follows yesterday's announcement of the CHIPS award, but the DARPA selection and production milestone are new developments that reinforce IBM's quantum leadership. The news is positive for IBM's long-term technology positioning, though the financial impact is not immediate.
At the time of this announcement, IBM was trading at $238.46 on NYSE in the Technology sector, with a market capitalization of approximately $223.7B. The 52-week trading range was $199.19 to $332.46. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.